Aligos Therapeutics
Develops liver- and viral-disease drug candidates, including a chronic hepatitis B program.
$7.02
After-hours close+0.17 (+2.48%)
At close$6.85(−3.11%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$2.44 | — | — |
| Aug 2026 | −$1.09 | −$0.14 | +87.2% |
| May 2026 | −$2.29 | −$2.21 | +3.5% |
| Mar 2026 | −$2.49 | −$1.91 | +23.2% |
| Nov 2025 | −$2.09 | −$3.04 | −45.5% |
The latest year is open to everyone — the 28 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Oct 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$2.44 | — | — | $4.9M | — | — |
| Aug 6, 2026 | −$1.09 | −$0.14 | +87.2% | $24.7M | $27.8M | +12.6% |
| May 7, 2026 | −$2.29 | −$2.21 | +3.5% | $250.0K | $2.8M | +1,032.0% |
| Mar 5, 2026 | −$2.49 | −$1.91 | +23.2% | $440.0K | $169.0K | −61.6% |
| Nov 6, 2025 | −$2.09 | −$3.04 | −45.5% | $266.7K | $741.0K | +177.9% |
The latest year is open to everyone — the 28 quarters behind it read with an account. Sign in | ||||||
| Aug 6, 2025 | ||||||
| May 6, 2025 | ||||||
| Mar 10, 2025 | ||||||
| Nov 6, 2024 | ||||||
| Aug 6, 2024 | ||||||
| May 7, 2024 | ||||||
| Mar 12, 2024 | ||||||
| Nov 2, 2023 | ||||||
| Aug 3, 2023 | ||||||
| May 4, 2023 | ||||||
| Mar 9, 2023 | ||||||
| Nov 2, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 4, 2022 | ||||||
| Mar 10, 2022 | ||||||
| Nov 4, 2021 | ||||||
| Aug 5, 2021 | ||||||
| May 10, 2021 | ||||||
| Mar 23, 2021 | ||||||
| Nov 25, 2020 | ||||||
| Oct 19, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||
| Jun 30, 2018 | ||||||
| Mar 31, 2018 | ||||||